Formulary Search Results for: apremilast
10.1.3 Drugs that suppress the rheumatic disease process - View Category
Restrictions:
Use in the treatment of Psoriatic Arthritis (PsA) is restricted to specialist initiation in adults with active psoriatic athritis who have had an inadequate response with at least two prior disease modifying anti-rheumatics drugs (DMARDs) or who are intolerant to such therapies.
Prescribing Notes:
- Specialist secondary care clinics continue to have responsibility for:
- providing prescription for the initiation pack
- all monitoring
- assessment of response
- GPs can obtain advice from specialist clinics (contact details provided with each patient request)
- Further information can be found in the accompanying GP Information sheet
For other indications please see chapter 13.5.3
13.5.3 Drugs affecting the immune response - View Category
Restrictions:
The treatment of moderate to severe chronic plaque psoriasis in adults patients who failed to respond to or who have a contraindication to, or are intolerant to other systemic therapy including ciclosporin, methotrexate or psoralen and ultraviolet-A light (PUVA) is restricted to specialist initiation.
Prescribing Notes:
- Specialist secondary care clinics continue to have responsibility for:
- providing prescription for the initiation pack
- all monitoring
- assessment of response
- GPs can obtain advice from specialist clinics (contact details provided with each patient request)
- Further information can be found in the accompanying GP Information sheet
For other indications please see chapter 10.1.3